综述

高脂饮食引发胃肠菌群改变与胃肠肿瘤关系的研究进展

  • 吴奇 ,
  • 卜乐 ,
  • 徐倍
展开
  • 1.安徽理工大学医学院 (安徽 淮南 232001 )
    2.上海市第十人民医院内分泌科 (上海 200072 )

收稿日期: 2023-08-23

  网络出版日期: 2024-01-24

基金资助

上海市 2021 年度“科技创新行动计划”自然科学基金项目(21ZR1449400)

Research progress of the relationship between high fat diet-Induced gastrointestinal microbiota and gastrointestinal cancer

  • Qi WU ,
  • Le BU ,
  • Bei. XU
Expand
  • *.School of Medicine,Anhui University of Science and Technology,Huainan 232001,China
    *.Department of Endocrinology and Metabolism,Shanghai Tenth People′s Hospital,Shanghai 200072,China

Received date: 2023-08-23

  Online published: 2024-01-24

摘要

在健康个体中,胃肠道内有害菌、有益菌等处于共生平衡状态,其稳态的打破与胃肠肿瘤发生密切相关。研究表明高脂饮食引发胃肠菌群改变,失调的菌可能通过影响菌群代谢产物、导致胃肠屏障受损、抑制抗肿瘤免疫等方式促进胃肠肿瘤的发生发展。本文主要就高脂饮食引发胃肠菌群改变与胃肠肿瘤的关系;在高脂饮食介导下,菌群失调促进胃肠肿瘤发生发展的可能机制进行综述,以期为胃肠肿瘤治疗提供新思路。

本文引用格式

吴奇 , 卜乐 , 徐倍 . 高脂饮食引发胃肠菌群改变与胃肠肿瘤关系的研究进展[J]. 实用医学杂志, 2024 , 40(1) : 123 -128 . DOI: 10.3969/j.issn.1006-5725.2024.01.022

Abstract

In healthy individuals, there is a favourable balance between commensal and potentially pathogenic bacteria. When the balance is broken, the host might suffer from gastrointestinal cancer. Studies have shown that high-fat diet can alter the composition of gastrointestinal microbiota,gastrointestinal microbiota may promote gastrointestinal cancer by affecting metabolites of gastrointestinal microbiota, leading to loss of gastrointestinal barrier function, suppressing anti-tumor immunity, etc. In this work, we will summary the current knowledge on relations and possible mechanisms of high-fat diet-associated gastrointestinal microbiota and gastrointestinal cancer. To provide new ideas for the treatment of gastrointestinal cancer.

参考文献

1 HE Y, LI Y, YANG X, et al. The dietary transition and its association with cardiometabolic mortality among Chinese adults, 1982-2012: a cross-sectional population-based study [J]. Lancet Diabetes Endocrinol, 2019, 7(7): 540-548.
2 庞邵杰, 贾珊珊, 方微, 等. 中国18~59 岁居民膳食脂肪酸的摄入状况及食物来源分析 [J]. 营养学报, 2022, 44(4): 366-370.
3 HUANG J, LUCERO-PRISNO D, ZHANG L, et al. Updated epidemiology of gastrointestinal cancers in East Asia [J]. Nat Rev Gastroenterol Hepatol, 2023, 20(5): 271-287.
4 WU Y, LI Y, GIOVANNUCCI E. Potential Impact of Time Trend of Lifestyle Risk Factors on Burden of Major Gastrointestinal Cancers in China [J]. Gastroenterology, 2021, 161(6): 1830-1841.e8.
5 ARIMA K, ZHONG R, UGAI T, et al. Western-Style Diet, pks Island-Carrying Escherichia coli, and Colorectal Cancer: Analyses From Two Large Prospective Cohort Studies [J]. Gastroenterology, 2022, 163(4): 862-874.
6 ARITA S, INAGAKI-OHARA K. High-fat-diet-induced modulations of leptin signaling and gastric microbiota drive precancerous lesions in the stomach [J]. Nutrition, 2019, 67-68: 110556.
7 LIU T, GUO Z, SONG X, et al. High-fat diet-induced dysbiosis mediates MCP-1/CCR2 axis-dependent M2 macrophage polarization and promotes intestinal adenoma-adenocarcinoma sequence [J]. J Cell Mol Med, 2020, 24(4): 2648-2662.
8 JIN D, HUANG K, XU M, et al. Deoxycholic acid induces gastric intestinal metaplasia by activating STAT3 signaling and disturbing gastric bile acids metabolism and microbiota [J]. Gut microbes, 2022, 14(1): 2120744.
9 FU T, COULTER S, YOSHIHARA E, et al. FXR Regulates Intestinal Cancer Stem Cell Proliferation [J]. Cell, 2019, 176(5): 1098-1112.e18.
10 GHOSH S, MOLCAN E, DECOFFE D, et al. Diets rich in n-6 PUFA induce intestinal microbial dysbiosis in aged mice [J]. Br J Nutr, 2013, 110(3): 515-523.
11 XU C, GU L, HU L, et al. FADS1-arachidonic acid axis enhances arachidonic acid metabolism by altering intestinal microecology in colorectal cancer [J]. Nat Commun, 2023, 14(1): 2042.
12 WANG T, BROWN N, MCCOY A, et al. Omega-3 Polyunsaturated Fatty Acids, Gut Microbiota, Microbial Metabolites, and Risk of Colorectal Adenomas [J]. Cancers(Basel), 2022, 14(18): 4443.
13 ZHANG H, ZHENG L, LI C, et al. Effects of gut microbiota on omega-3-mediated ovary and metabolic benefits in polycystic ovary syndrome mice [J]. J Ovarian Res, 2023, 16(1): 138.
14 YOO W, ZIEBA J, FOEGEDING N, et al. High-fat diet-induced colonocyte dysfunction escalates microbiota-derived trimethylamine N-oxide [J]. Science, 2021, 373(6556): 813-818.
15 WU D, CAO M, PENG J, et al. The effect of trimethylamine N-oxide on Helicobacter pylori-induced changes of immunoinflammatory genes expression in gastric epithelial cells [J]. Int Immunopharmacol, 2017, 43: 172-178.
16 JALANDRA R, DALAL N, YADAV A, et al. Emerging role of trimethylamine-N-oxide (TMAO) in colorectal cancer [J]. Appl Microbiol Biotechnol, 2021, 105(20): 7651-7660.
17 MIRJI G, WORTH A, BHAT S, et al. The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer [J]. Sci Immunol, 2022, 7(75): eabn0704.
18 WANG L, GONG Z, ZHANG X, et al. Gut microbial bile acid metabolite skews macrophage polarization and contributes to high-fat diet-induced colonic inflammation [J]. Gut Microbes, 2020, 12(1): 1-20.
19 YU J, ZHENG J, QI J, et al. Bile acids promote gastric intestinal metaplasia by upregulating CDX2 and MUC2 expression via the FXR/NF-κB signalling pathway [J]. Int J Oncol, 2019, 54(3): 879-892.
20 SONG X, AN Y, CHEN D, et al. Microbial metabolite deoxycholic acid promotes vasculogenic mimicry formation in intestinal carcinogenesis [J]. Cancer Sci, 2022, 113(2): 459-477.
21 HUANG C, TAN H, SONG M, et al. Maternal Western diet mediates susceptibility of offspring to Crohn's-like colitis by deoxycholate generation [J]. Microbiome, 2023, 11(1): 96.
22 WANG B, KONG Q, LI X, et al. A High-Fat Diet Increases Gut Microbiota Biodiversity and Energy Expenditure Due to Nutrient Difference [J]. Nutrients, 2020, 12(10): 3197.
23 LIANG Y, RAO Z, DU D, et al. Butyrate prevents the migration and invasion, and aerobic glycolysis in gastric cancer via inhibiting Wnt/β-catenin/c-Myc signaling [J]. Drug Dev Res, 2023, 84(3): 532-541.
24 KA?MIERCZAK-SIEDLECKA K, MARANO L, MEROLA E, et al. Sodium butyrate in both prevention and supportive treatment of colorectal cancer [J]. Front Cell Infect Microbiol, 2022, 12: 1023806.
25 ASAHARA T, SHIMIZU K, NOMOTO K, et al. Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7 [J]. Infect Immun, 2004, 72(4): 2240-2247.
26 WANG R, TAO B, FAN Q, et al. Fatty-acid receptor CD36 functions as a hydrogen sulfide-targeted receptor with its Cys333-Cys272 disulfide bond serving as a specific molecular switch to accelerate gastric cancer metastasis [J]. E Bio Med, 2019, 45: 108-123.
27 BLACHIER F, ANDRIAMIHAJA M, LARRAUFIE P, et al. Production of hydrogen sulfide by the intestinal microbiota and epithelial cells and consequences for the colonic and rectal mucosa [J]. Am J Physiol Gastrointest Liver Physiol, 2021, 320(2): G125-G135.
28 陈善稳, 王鹏远, 刘玉村. 硫化氢与结直肠癌相关性及其抗肿瘤药物研发的进展 [J]. 中华胃肠外科杂志, 2017, 20(07): 834-837.
29 ZHANG W, AN Y, QIN X, et al. Gut Microbiota-Derived Metabolites in Colorectal Cancer: The Bad and the Challenges [J]. Front Oncol, 2021, 11: 739648.
30 NABHANI Z AL, DULAUROY S, LéCUYER E, et al. Excess calorie intake early in life increases susceptibility to colitis in adulthood [J]. Nat Metab, 2019, 1(11): 1101-1109.
31 CHEN J, XUE F, DU W, et al. An Endogenous HS-Activated Nanoplatform for Triple Synergistic Therapy of Colorectal Cancer [J]. Nano Lett, 2022, 22(15): 6156-6165.
32 HE C, CHENG D, PENG C, et al. High-Fat Diet Induces Dysbiosis of Gastric Microbiota Prior to Gut Microbiota in Association With Metabolic Disorders in Mice [J]. Front Microbiol, 2018, 9: 639.
33 SUKI M, LEIBOVICI WEISSMAN Y, BOLTIN D, et al. Helicobacter pylori infection is positively associated with an increased BMI, irrespective of socioeconomic status and other confounders: a cohort study [J]. Eur J Gastroenterol Hepatol, 2018, 30(2): 143-148.
34 MARQUES M, COSTA A, OSóRIO H, et al. Helicobacter pylori PqqE is a new virulence factor that cleaves junctional adhesion molecule A and disrupts gastric epithelial integrity [J]. Gut microbes, 2021, 13(1): 1-21.
35 TRAULSEN J, ZAGAMI C, DADDI A, et al. Molecular modelling of the gastric barrier response, from infection to carcinogenesis [J]. Best Pract Res Clin Gastroenterol, 2021, 50-51: 101737.
36 ZENG N, WU F, LU J, et al. High-fat diet impairs gut barrier through intestinal microbiota-derived reactive oxygen species [J]. Sci China Life Sci, 2023.
37 YANG J, WEI H, ZHOU Y, et al. High-Fat Diet Promotes Colorectal Tumorigenesis Through Modulating Gut Microbiota and Metabolites [J]. Gastroenterology, 2022, 162(1): 135-149.e2.
38 MISHRA S, WANG B, JAIN S, et al. A mechanism by which gut microbiota elevates permeability and inflammation in obese/diabetic mice and human gut [J]. Gut, 2023, 72(10): 1848-1865.
39 HU Y, PANG W, HUANG Y, et al. The Gastric Microbiome Is Perturbed in Advanced Gastric Adenocarcinoma Identified Through Shotgun Metagenomics [J]. Front Cell Infect Microbiol, 2018, 8: 433.
40 DE WAAL G, DE VILLIERS W, FORGAN T, et al. Colorectal cancer is associated with increased circulating lipopolysaccharide, inflammation and hypercoagulability [J]. Sci Rep, 2020, 10(1): 8777.
41 BEAM A, CLINGER E, HAO L. Effect of Diet and Dietary Components on the Composition of the Gut Microbiota [J]. Nutrients, 2021, 13(8): 2795.
42 MANILLA V, DI TOMMASO N, SANTOPAOLO F, et al. Endotoxemia and Gastrointestinal Cancers: Insight into the Mechanisms Underlying a Dangerous Relationship [J]. Microorganisms, 2023, 11(2): 267.
43 HEATH B, GONG W, TANER H, et al. Saturated fatty acids dampen the immunogenicity of cancer by suppressing STING [J]. Cell Rep, 2023, 42(4): 112303.
44 SIMPSON R, SHANAHAN E, BATTEN M, et al. Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiome [J]. Nat Med, 2022, 28(11): 2344-2352.
45 BEYAZ S, CHUNG C, MOU H, et al. Dietary suppression of MHC class II expression in intestinal epithelial cells enhances intestinal tumorigenesis [J]. Cell Stem Cell, 2021, 28(11): 1922-1935.e5.
46 O'KEEFE S, LI J, LAHTI L, et al. Fat, fibre and cancer risk in African Americans and rural Africans [J]. Nat Commun, 2015, 6: 6342.
47 MEHTA R, NISHIHARA R, CAO Y, et al. Association of Dietary Patterns With Risk of Colorectal Cancer Subtypes Classified by Fusobacterium nucleatum in Tumor Tissue [J]. JAMA Oncol, 2017, 3(7): 921-927.
48 JIANG S, XIE Y, XIAO X, et al. Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer [J]. Cell Host Microbe, 2023, 31(5): 781-797.e9.
49 ZHANG X, YU D, WU D, et al. Tissue-resident Lachnospiraceae family bacteria protect against colorectal carcinogenesis by promoting tumor immune surveillance [J]. Cell Host Microbe, 2023, 31(3): 418-432.e8.
50 MARTíNEZ-GARAY C, DJOUDER N. Dietary interventions and precision nutrition in cancer therapy [J]. Trends Mol Med, 2023, 29(7): 489-511.
51 LIANG S, XU L, ZHANG D, et al. Effect of probiotics on small intestinal bacterial overgrowth in patients with gastric and colorectal cancer [J]. Turk J Gastroenterol, 2016, 27(3): 227-232.
52 ZHENG D, LI R, AN J, et al. Prebiotics-Encapsulated Probiotic Spores Regulate Gut Microbiota and Suppress Colon Cancer [J]. Adv Mater, 2020, 32(45): e2004529.
文章导航

/